参考文献/References:
[1] 李春艳,朱安泰.糖尿病视网膜病变并发玻璃体积血手术时机选择[J].新乡医学院学报,2018,33(8):731-734.
LI C Y,ZHU A T.Choice of the operative opportunity for diabetic retinopathy complicated with vitreous hemorrhage[J].J Xinxiang Med Univ,2018,33(8):731-734.
[2] AREVALO J F,LASAVE A F,WU L,MAIA M,DIAZ-LLOPIS M,ALEZZANDRINI A A,et al.Intravitreal bevacizumab for proliferative diabetic retinopathy:results from the pan-american collaborative retina study group (pacores) at 24 months of follow-up[J].Retina,2017,37(2):334-343.
[3] YANG X,HUO F,LIU B,LIU J,CHEN T,LI J,et al.Crocin inhibits oxidative stress and pro-inflammatory response of microglial cells associated with diabetic retinopathy through the activation of PI3K/AKT signaling pathway[J].J Mol Neurosci,2017,61(4):581-589.
[4] BEHL T,KAUR I,KOTWANI A.Implication of oxidative stress in progression of diabetic retinopathy[J].Surv Ophthalmol,2016,61(2):187-196.
[5] 杨萍,崔云秋,于婷,全姬善.人参皂苷Rg3剂型的研究进展[J].国际药学研究杂志,2017,44(6):514-517.
YANG P,CUI Y Q,YU T,QUAN J S.Research progress in ginsenoside Rg3 dosage form[J].J Int Pharm Res,2017,44(6):514-517.
[6] 杨佳丹,向荣凤,戴青,来小丹.人参皂苷Rg3对模拟高原缺氧大鼠的抗疲劳效应和骨骼肌线粒体功能的影响[J].第三军医大学学报,2019,41(2):110-115.
YANG J D,XIANG R F,DAI Q,LAI X D.Effects of ginsenoside Rg3 on fatigue resistance and skeletal muscle mitochondrial function in rats exposed to a simulated altitude of 5000 m[J].Acta Acad Med Mil Tert,2019,41(2):110-115.
[7] 耿良,杨彩玲,田同德,俞静,孙维敏,金玺圆,等.人参皂苷Rg3和PEG-PLGA-Rg3纳米微粒对人血管内皮细胞侵袭和微管形成能力的影响[J].北京中医药大学学报,2014,37(9):611-615.
GENG L,YANG C L,TIAN T D,YU J,SUN W M,JIN X Y,et al.Influences of nanoparticles Rg3 and PEG-PLGA-Rg3 on endothelial cells invasion and tube formation[J].J Beijing Univ TCM,2014,37(9):611-615.
[8] USTUNDAG Y,AKDOGAN M,DEMIRCI H,GNAY L,HUYSAL K,CEVIK S G,et al.High density lipoprotein- 3 in diabetic retinopathy patients:relationship to total antioxidant capacity and nitric oxide level[J].Int Eye Sci,2017,17(12):2197-2202.
[9] 陈莹恩,杨秀丽,赵奕霖,孙海燕,王显良,赵国安.辛伐他汀对慢性心力衰竭幼兔心肌凋亡及氧化应激机制的影响[J].中华实用儿科临床杂志,2017,32(13):1022-1025.
CHEN Y E,YANG X L,ZHAO Y L,SUN H Y,WANG X L,ZHAO G A.Effects of Simvastatin on myocardial apoptosis and oxidative stress mechanism in immature rabbits with chronic heart failure[J].Chin J Appl Clin Pediatr,2017,32(13):1022-1025.
[10] SHAHAR E,ATTIAS U,SAVULESCU D,GENIZIN J,GAVISH M,NAGLER R.Oxidative stress,metalloproteinase and LDH in children with intractable and non-intractable epilepsy as reflected in salivary analysis[J].Epilepsy Res,2014,108(1):117-124.
[11] CHO R L,YANG C C,LEE I T,LIN C C,CHI P L,HSIAO L D,et al.Lipopolysaccharide induces ICAM-1 expression via a c-Src/NADPH oxidase/ROS-dependent NF-κB pathway in human pulmonary alveolar epithelial cells[J].Am J Physiol Lung Cell Mol Physiol,2016,310(7):639-657.
[12] MOYA A,SAKAMAKI K,MASON B M,HUISMAN L,FORET S,WEISS Y,et al.Functional conservation of the apoptotic machinery from coral to man:the diverse and complex Bcl-2 and caspase repertoires of Acropora millepora[J].BMC Genomics,2016,17(1):62-99.
[13] 唐俊,左满花.人参皂苷Rg3对糖尿病肾脏疾病大鼠氧化应激和凋亡的影响[J].中国糖尿病杂志,2017,25(10):929-932.
TANG J,ZUO M H.Effects of Ginsenoside Rg3 on oxidative stress and apoptosis in diabetic kidney disease rats[J].Chin J Diabetes,2017,25(10):929-932.
[14] 徐家窈,冼文光,刘俐娜.血清VEGF及ICAM-1水平与糖尿病视网膜病变患者微血管损伤的关系[J].中国老年学杂志,2017,37(8):2000-2002.
XU J Y,XIAN W G,LIU L N.Relationship between serum VEGF and icam-1 levels and microvascular injury in patients with diabetic retinopathy[J].Chin J Gerontol,2017,37(8):2000-2002.
[15] KOMATSU W,KISHI H,YAGASAKI K,OHHIRA S.Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-κB and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages:Possible involvement of NADPH oxidase-derived reactive oxygen species[J].Eur J Pharmacol,2018,833(11):411-424.
[16] YU J S L,WEI C.Proliferation,survival and metabolism:the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination[J].Development,2016,143(17):3050-3060.
相似文献/References:
[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.